Table 3.
Baseline data, pyrogenic factors and use of antibiotics and thrombolysis
| Total n=44 | No pyrexia n=28 | Pyrexia n=16 | |||
|---|---|---|---|---|---|
|
Sex |
|
|
|
|
|
| |
Male |
21 |
15 |
6 |
|
| |
Female |
23 |
13 |
10 |
|
|
Mean Age in years, (SD) |
|
71.9 (11.4) |
71.9 (11.7) |
71.9 (11.3) |
p=0.990 |
|
Stroke Subtype |
|
|
|
|
|
| |
TACS |
14 |
5 |
9 |
TACS vs |
| |
PACS |
19 |
14 |
5 |
non-TACS |
| |
LACS |
6 |
6 |
0 |
χ2=6.9 |
| |
POCS |
5 |
3 |
2 |
p=0.009 |
|
Stroke severity |
|
|
|
|
|
| |
Median NIHSS (IQR) |
7 (3–14) |
6.5 (3–10) |
12 (5–18) |
p=0.0381 (MWU) |
|
Temperature |
|
|
|
|
|
| |
Time to peak, median hours after stroke, (IQR) |
35.5 (19–53.8) |
36.0 (7.8-59.3) |
32.5 (22.8-51.3) |
p=0.652 (MWU) |
|
No. with ≥1 pyrogenic factor identified* |
|
16 (36%) |
7 (25%) |
9 (56%) |
|
| |
Urinary catheter |
8 |
3 |
5 |
|
| |
NG tube |
9 |
4 |
5 |
|
| |
Surgical procedure |
4 |
2 |
2 |
|
| |
DVT |
0 |
0 |
0 |
|
| |
Infection: urinary |
2 |
0 |
2 |
|
| |
Infection: respiratory |
7 |
4 |
3 |
|
|
Antibiotics |
|
10 |
4 (14%) |
6 (38%) |
|
|
Paracetamol |
|
13 |
7 (25%) |
6 (38%) |
|
|
Thrombolysis |
|
3 |
1 (4%) |
2 (13%) |
|
|
90 day mRS |
|
|
|
|
|
| |
mRS ≤2 |
19 |
15 |
4 |
χ2=3.5 |
| mRS ≥3 | 25 | 13 | 12 | p=0.061 |
*Some patients had more than 1 potential cause of pyrexia. Pyrexia was defined as tympanic temperature ≥37.5°C. SD: standard deviation; TACS: total anterior circulation stroke; PACS: partial anterior circulation stroke; LACS: lacunar stroke; POCS: posterior circulation stroke; NIHSS: National Institute of Health Stroke Score; IQR: interquartile range; MWU: Mann Whitney U test; NG: nasogastric; DVT: deep venous thrombosis; mRS: modified Rankin Score.